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doi:10.1016/j.ejvs.2008.08.015Abstract Objective: To evaluate whether ligation of the sapheno-femoral junction (SFJ)
improves the 2-year results of endovenous laser ablation (EVA).
Methods: Forty-three symptomatic patients with bilateral varicose veins were studied in which
one limb was randomly assigned to receive EVA without SFJ ligation, and the other limb
received EVA with SFJ ligation. Recurrence of varicose veins and abolition of great saphenous
vein (GSV) reflux on duplex ultrasound imaging, and venous clinical severity score (VCSS) were
investigated at 6, 12, and 24 months after treatment.
Results: Two-year life table analysis showed freedom fromgroin varicose vein recurrence in 83% of
43 limbs (95%CI; 67e95%) in the EVAwithout ligation group and in 87%of 43 limbs (95%;CI 73e97) of
limbs in the EVA with ligation group (PZ 0.47). Thirty-eight (88%) treated GSV segments were
ablated completely in the EVA without ligation group and 42 (98%) in the EVA with ligation group
(N.S.). Groin recurrence was due to an incompetent SFJ/GSV (9%) and to incompetent tributaries
(7%) in the EVAwithout ligation group and due to neovascularisation (12%) in the EVAwith ligation
group. The VCSS improved significantly and was comparable in both groups.
Conclusion: The addition of SFJ ligation to EVAmakes no difference to the short-term outcome of
varicose veins treatment. Establishing whether SFJ ligation results in a poorer long-term outcome
because of neovascularisation needs to be studied in larger populations with longer follow-up.
Registration number: ISRCTN60300873 (http://www.controlled-trials.com).
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Endovenous laser ablation (EVA) is used to treat varicose
veins due to reflux in the great saphenous vein (GSV). It
causes thermal damage to the wall of the vein, resulting in
destruction of the endothelium and in denaturation of the
collagen in the media, accompanied by fibrotic occlusion of
the vein.1 Critics of endovenous techniques in the treat-
ment of varicose veins dispute the wisdom of not ligating
the proximal GSV and groin tributaries at the sapheno-
femoral junction (SFJ), arguing that groin tributaries may
remain patent, which might promote recurrence of varicose
veins. Others argue that avoiding surgical disruption of the
SFJ, as occurs during ligation, may actually reduce neo-
vascularisation, leading to a reduced rate of recurrence.2
Other suggested reasons for vein ligation are failure of vein
occlusion based on a ‘‘too large’’ diameter of the saphe-
nous vein, and the development of a deep vein thrombosis
or a pulmonary embolus.3
The aim of this single-centre randomized clinical trial
was to evaluate the 2-year results of EVA of the great
saphenous vein with and without SFJ ligation in patients
with primary bilateral varicose veins.
Patients and methods
Consecutive patients with primary bilateral varicose veins,
referred to our hospital from March 2003 to February 2005,
were considered for inclusion in this study. The study
protocol was approved by the regional ethics committee of
the Mesos Medical Centre, Utrecht, The Netherlands.
The inclusion criteria were patients with primary symp-
tomatic varicose veins, CEAP clinical class C2 venous
disease4, age 20e75 years, SFJ incompetence, and GSV
reflux from the groin to below the knee, defined as retro-
grade flow lasting longer than 0.5 s on Duplex scanning (ATL
3500 HDI, ATL ultrasound, Bothell, WA, USA). Incompetence
in perforator veins, tributaries at the SFJ and accessory
saphenous veins were defined as bidirectional flow. Reasons
for exclusion were previous venous surgery, a history of
suspected or proven deep venous thrombosis, CEAP clinical
class C3-6 venous disease, deep venous reflux, incompe-
tence of the perforating veins below the knee, reflux of the
GSV just to the knee, duplication of the GSV, patient refusal
and others. All patients fulfilling the inclusion criteria
received written and verbal information about the aims and
content of the study in accordance with the Helsinki
Declaration. After they had given written informed
consent, patients were randomly assigned using numbered
and sealed envelopes containing data concerning the side
of SFJ ligation. Patients received bilateral treatment in
which one limb received EVA without SFJ ligation, whereas
the other limb received EVA with SFJ ligation. The proce-
dures were performed as day-care procedures within
6 weeks of randomization.
One surgeon experienced in EVA techniques and varicose
vein surgery performed all treatments. According to our
clinic protocol, all patients received low-molecular-weight
heparin as thrombosis prophylaxis on the day of treatment.
A standard set of information was collected at each visit.
Physicians used the venous clinical severity score (VCSS)5 toassess the signs and symptoms of venous disease and
completed the CEAP classification. We measured the
operative time for treatment of each limb: time to
complete laser procedure versus time for laser procedure
plus time to complete SFJ ligation (skin-to-skin).
Postoperatively, information was collected about
complications, wound closure (using the modified Hollander
cosmetics score, MHCS6), the mean pain score and the
mean reduction in physical activity score (both assessed
with a linear analogue scale for grading severity on a score
from 0 to 10), the mean duration of sick leave, recurrent
varicose veins demonstrated by Duplex ultrasound, and
VCCS scores. Duplex ultrasound detected recurrent vari-
cose veins were classified in accordance with Stonebridge.7
Abolition of GSV reflux was demonstrated by its complete
occlusion or obliteration, confirmed by Duplex ultrasound.
Special attention was paid to visualization of the GSV after
EVA to detect recanalisation of this vein.
There were differences in the delivery of laser energy.
EVA was performed with an 810-nm diode laser (Diomed
Inc, Andover, MA) using 12-Watt intermittent laser power
(1 s on, 1 s off) in the first 40 limbs (47%) in 20 patients, and
using 14-Watt continuous laser power (at a pullback rate of
0.2 cm/s) in the next 46 limbs (53%) in 23 patients. The
change in delivery of laser energy from intermittent to
continuous was based on our first 100 procedures8 and in
accordance with Min et al.9 It was assumed that a higher
dose of laser energy (as per continuous laser protocol) in
combination with a slow pullback rate would improve the
occlusion rate.9,10
The EVA procedure has been described before.8 In brief,
the GSV, 5 cm below the knee, was accessed under ultra-
sound guidance and the tip of the laser fibre was positioned
0.5e1 cm below the SFJ. Under ultrasound monitoring,
250 mL of tumescent local anaesthetic (200 mL physiolog-
ical saline (0.9%), 40 mL lidocaine (1%), and adrenaline
(1: 100,000) neutralized with 10 mL sodium bicarbonate
(8.4%)) was administered within the facial sheath of the
GSV to achieve analgesia, compression of the vein, and
a heat sink. In the case of spinal or general anaesthesia,
250 ml NaCl 0.9% was administered. Manual compression
was applied over the GSV while 12-Watt intermittent
(1 pulse on, 1 pulse off) or 14-Watt continuous laser energy
was delivered from 0.5 cm to 1 cm below the SFJ to the
access site at a pullback rate of 0.2 cm/s. High ligation was
performed through a 4-cm-long incision in the groin, with
flush division of the GSV and division of all tributaries
behind the second level of division. The groin incision was
closed with tissue adhesive Dermabond (Johnson & John-
son, NJ, USA). After the procedure, a thigh length gradu-
ated compression stocking (20e30 mmHg) was worn day
and night for 1 week. Aceclofenac 100 mg twice daily for
1 week was prescribed for postoperative pain. Patients
were instructed to walk immediately after the procedure
and were encouraged to resume normal activities and work
as soon as possible.
The primary outcome measure was freedom from
recurrent varicose veins in the groin, as assessed by duplex
ultrasonography, 2 years after treatment. Secondary
outcomes were abolition of reflux in the GSV, VCSS scores,
freedom from overall recurrent varicose veins, and proce-
dural complications.
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limbs (100%), 82 limbs (95%), and 78 limbs (91%), respec-
tively. Two patients were lost to follow-up at 12 months
because of discomfort during duplex ultrasound examina-
tion and 2 at 24 months because of pregnancy. Earlier
ultrasound scanning did not detect evidence of groin
recurrence and revealed abolition of GSV reflux in these
4 patients; their VCSS scores had also improved.
Statistical analysis
We hypothesized that high ligation would not improve the
outcome of EVA 2 years after treatment. To our knowledge
in 2003, there were no randomized controlled trial data
available comparing different options for venous surgery in
the same patient with primary varicose veins. So, a formal
power calculation was not performed. The precision of
a trial with 43 as the denominator will yield a standard
error of 5.7% (pertaining to a proportion of 85%). Analysis of
the outcome was on an intention-to-treat basis. Data from
the assessments were coded and analyses were performed
using SAS 8.2 statistical programs (SAS Institute, North
Carolina, USA) and Microsoft Excel (Microsoft Redmond,
Washington, USA). The unit of the primary analyses was
limb, taking into account the paired nature of the study
design. The difference in primary outcome for EVA without
ligation versus EVA with ligation was assessed by means ofAssessed for eligi
(n=145)  
Analysed (n=39)
Lost to follow-up (n=4)
Allocated to EVA without ligation
(n=43)
Received allocated intervention
(n=43)
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Figure 1 CONSORT flow chart. Ethe McNemar’s test, a matched pairs test for a 2 2 table.
Freedom from duplex-detected recurrence was graphically
depicted by means of KaplaneMeier curves, assuming that
the event took place exactly half way two follow-up visits
and difference assessed by means of the log-rank test. All
secondary analyses on count variables were tested with the
McNemar’s test and continuous variables with paired t-test.
Multivariate repeated measures general linear modelling
was used to compare scores for VCSS over time. P< 0.05
was considered to indicate a statistical significant
difference.
Results
Of 145 patients assessed for the trial, 49 (34%) met the
inclusion criteria and 43 (30%) agreed to randomization
(Fig. 1). The median age of the patients was 45 years (range
23e74). Thirty-six patients (84%) were female and 27 (63%)
had a body mass index less than 25 kg/m2. Baseline char-
acteristics of the GSV are given in Table 1. The mean oper-
ative time, was significantly longer in the EVA with ligation
group than in the EVA group (32 S.D. 5.8 min versus 20 S.D.
6.3 min; P< 0.0001). The mean length of treated vein was
statistically significantly greater (43 S.D. 2.8 cm versus 41
S.D. 3.1 cm; P< 0.0001) in the EVA group but this was not of
clinical importance. Reflux in the small saphenous vein (SSV)
was treated with sapheno-popliteal ligation in 4 of the 86bility
Excluded (n=102) 
Not meeting inclusion criteria (n=48)
Not meeting Duplex criteria (n=42)
Refused to participate (n=12)
Lost to follow-up (n=4)
Allocated to EVA with ligation
(n=43)
Received allocated intervention
(n=43)
Analysed (n=39)
VA, endovenous laser ablation.
Table 1 Preoperative duplex results
EVA without
ligation (nZ 43)
EVA with
ligation (nZ 43)
P-
value
In GSV at SFJa
Diameter (cm) 0.9 (0.4e1.7) 0.9 (0.5e1.6) N.S.
Reflux time (s) 3.4 (0.5e6.0) 3.3 (0.5e6.4) N.S.
In GSV mid thigha
Diameter (cm) 0.7 (0.4e1.6) 0.6 (0.3e1.6) N.S.
Reflux time (s) 3.7 (0.5e6.0) 3.6 (0.5e6.0) N.S.
In GSV at kneea
Diameter (cm) 0.6 (0.4e1.6) 0.6 (0.3e1.6) N.S.
Reflux time (s) 4.0 (0.5e6.0) 3.9 (0.5e6.0) N.S.
In GSV mid calfa
Diameter (cm) 0.4 (0.2e0.8) 0.4 (0.2e0.6) N.S.
Reflux time (s) 1.2 (0.0e6.0) 1.2 (0.0e6.0) N.S.
External pudendal vein
Reflux 0 1 N.S.
No reflux 28 27
Not visible 15 15
Superficial epigastric vein
Reflux 2 1 N.S.
No reflux 28 28
Not visible 13 14
Superficial circumflex iliac vein
Reflux 0 2 N.S.
No reflux 23 25
Not visible 20 16
Anterior saphenous vein
Reflux 3 6 N.S.
No reflux 32 30
Not visible 8 7
Posterior saphenous vein
Reflux 5 4 N.S.
No reflux 28 30
Not visible 10 9
Superficial saphenous vein
Reflux 0 0 N.S.
No reflux 35 33
Not visible 8 10
GSV, great saphenous vein; SFJ, sapheno-femoral junction, and
N.S.Z not statistically significant.
a Values are mean (range).
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Figure 2 KaplaneMeier life table analysis of freedom of A
groin varicose vein recurrence and B overall varicose vein
recurrence.
716 B.C.V.M. Disselhoff et al.limbs affected (5%); 2 in each group. At 6 weeks, residual
non-GSV varicose veins in 18 limbs underwent sclerotherapy
with polidocanol 1% (Aethoxysclerol, Kreussler, Germany)
with the intention of removing all varicosities. The mean
reduction in physical activity score during the first 10 days
after treatment was 2.1 (range 0e8) and the mean duration
of sick leave was 0.6 days (range 0e6).
Primary outcome
Two-year life table analysis (Fig. 2) showed freedom from
varicose vein recurrence in the groin in 83% of 43 limbs (95%CI; 67e95) in the EVA group and in 87% of 43 limbs (95%; CI
73e97) in the EVA with ligation group (PZ 0.47). In the EVA
without ligation group, 4 limbs (9%) had type 1a varicose
vein recurrence and no improvement in VCSS scores
requiring additional SFJ ligation at the 6-month follow-up.
Three (7%) limbs had type 1B varicose veins recurrence
(anterior accessory saphenous vein) at the 12-month
follow-up. No improvement in VCSS score was recorded in 2
limbs and these patients required additional sclerotherapy.
In the EVA with ligation group, 5 limbs (13%) had type 1C
varicose veins recurrence in whom no improvement in VCSS
score was recorded in 3 limbs. Sclerotherapy was per-
formed in 2 limbs of these patients (Table 1).
Secondary outcomes
In the EVA without ligation group 38 (88%) treated GSV
segments were ablated completely (continuous exposure
nZ 22, 95%, intermittent nZ 16, 80%) and in the EVA with
ligation group 42 (98%) treated GSV segments (continuous
nZ 23, 100%, intermittent nZ 22, 96%. N.S.). Although
continuous exposure resulted in abolition of GSV reflux in
Randomized Clinical Trial Comparing Endovenous Laser Ablation 717more limbs than did intermittent exposure (98% (45/46)
versus 88% (35/40), N.S., respectively), the differences
between the two groups were not statistically significant.
At the 12- and 24-month follow-ups, recanalisation of the
GSV was not observed in either group.
VCSS scores improved significantly in both groups, but the
differences between the groups were not significant and
were independent of time since the procedure (Table 2).
Two-year life table analysis showed freedom from
overall varicose vein recurrence in 71% of limbs (95% CI;
51e87) in the EVA group and in 73% of limbs (95% CI; 53e87)
in the EVA with ligation group (N.S.), respectively (Fig. 2).
There were no significant differences between the groups
concerning bruising (54% in the EVA group and 58% in the
EVA with ligation group, N.S.), pain score (3.6 S.D. 2.1 and
3.6 S.D. 2.4, N.S.), tightness along the course of the GSV
(84% and 79%, N.S.), and superficial thrombophlebitis (7%
and 2%, N.S.). No patient had a skin burn and there was no
major complication such as deep vein thrombosis and/or
pulmonary embolism. Wound complications occurred inTable 2 Recurrent varicose veins demonstrated at Duplex
ultrasound and scores for VCCS
Baseline 6 Month
(nZ 43)
1 Year
(nZ 41)
2 Year
(nZ 39)
Type 1a recurrence
EVA 4 0 0
EVA with ligation 0 0 0
Type 1b recurrence
EVA 0 3 0
EVA with ligation 0 0 0
Type 1c recurrence
EVA 0 0 0
EVA with ligation 0 2 3
Type 2a recurrence
EVA 0 0 0
EVA with ligation 0 0 0
Type 2b recurrence
EVA 0 0 3
EVA with ligation 1 1 3
Saphenous vein recurrence
EVA 0 1 1
EVA with ligation 0 0 1
No recurrence
EVA 39 35 31
EVA with ligation 42 39 32
VCSS scorea
EVA 3.1 (1e5) 1.0 (0e4) 0.5 (0e2) 0.5 (0e2)
EVA with ligation 3.1 (1e5) 0.9 (0e3) 0.5 (0e2) 0.5 (0e2)
Type 1a: incompetent great saphenous vein (GSV). Type 1b:
incompetent tributaries. Type 1c: neovascularisation defined as
serpentine tributaries arising from the ligated SFJ. Type 2a:
cross-groin connections. Type 2b: thigh perforators. EVA,
endovenous laser ablation. and VCSS, venous clinical severity
score.
a Values are mean (range).four limbs in the EVA with ligation group (haematoma,
nZ 2; dehiscence, nZ 1; superficial groin infection, nZ 1)
but in none in the EVA group. None of the wound compli-
cations required surgical treatment. The proportion of
patients in the EVA with ligation group with an optimal
wound evaluation score (MHCSZ 6) was 74% (32/43) at
10 days and 95% (41/43) at 6 weeks after treatment.
Discussion
In this single-centre intra-patient study, we found no
difference in short-term outcome between EVA alone and
EVA with SFJ ligation. A tendency was observed that SFJ
ligation, resulted in a poorer long-tem outcome due to
neovascularization The VCSS improved significantly and was
comparable in both groups. EVA proved to be very effective
in causing ablation of the GSV with a maximum diameter of
17 mm: flush occlusion with the femoral vein was found in
43 (100%) limbs in the EVA with ligation group and occlusion
from 1 cm below the SFJ was demonstrated in 40 (93%)
limbs in the EVA without ligation group. Two earlier reports
of EVA with SFJ ligation reported comparable results: Chang
and Chua11 reported a success rate of 96.8% in 244 limbs
followed up to 28 months, and Huang et al.12 reported 100%
GSV occlusion in 94 limbs with a median follow-up of
6 months. A systematic review of EVA alone by Mundy
et al.13 reported a GSV occlusion rate of 87.9e100%. In our
study, we found that recurrent varicose veins in the groin
were due to an incompetent SFJ/GSV in four limbs (9%) in
the EVA group but in none (0%) of the EVA with ligation
group. Failure to occlude the proximal GSV and/or early
recanalisation are reported in fewer than 10% of veins after
EVA.14Proebstle et al.15 suggested that pre-treatment
diameter does not influence the success of EVA although
the laser energy delivered might need to be adjusted. We
found that continuous exposure tended to be more effec-
tive than intermittent exposure in abolishing GSV reflux (in
98% versus 88% of limbs, respectively; N.S.), although all
the continuous exposure treatments were in the later part
of our series. As stated by other authors 16e19 successful
GSV ablation depends on the mode and amount of laser
energy delivered, laser wavelength, and pullback rate, but
also on methodological aspects, such as the use of peri-
venous infiltration, manual compression over the vein
during the procedure, and a fibre tip position 0.5e1 cm
below the SFJ. These aspects are not considered further in
this article.
Groin recurrence due to incompetence of the anterior
accessory saphenous vein occurred in three limbs (7%) after
EVA alone but in none (0%) after EVA with ligation. Reflux in
SFJ tributaries such as the anterior accessory saphenous
vein is an important cause of recurrence. Garner20 reported
that of 141 groin recurrences after surgical stripping, 61
(43%) were due to a persistent anterior accessory saphe-
nous vein. In our study, we found that of 206 (80%) visible
SFJ tributaries at preoperative Duplex scanning, 18 (9%) had
reflux in one or more SFJ tributaries; these were treated
with sclerotherapy 6 weeks after EVA. Non-refluxing GSV
tributaries were found in 198 limbs (77%) at Duplex scan-
ning, of which only 3 (1.5%) resulted in recurrence. In
accordance with Theivacumar18, we believe that non-
refluxing GSV tributaries should not be treated as part of
718 B.C.V.M. Disselhoff et al.the primary procedure because they do not have an adverse
effect on outcome 2 years after EVA.
We observed groin vein recurrence due to neo-
vascularization in five limbs (12%) after EVA with ligation
and in none (0%) after EVA alone. In their prospective study
comparing radiofrequency ablation (VNUS Closure) and
surgical stripping, Kianifard et al.19 did not observe neo-
vascularization at the SFJ in any of the patients who had
undergone radiofrequency ablation but did in 11% of
patients who underwent surgical stripping. According to
van Rij et al.22, the rate of groin varicose vein recurrence
after adequate surgery is 23%, of which neovascularization
accounts for 85%. The notion that neovascularization in the
groin after surgical treatment leads to recurrence is sup-
ported by histological evidence. Glass21 described healing
angiogenesis induced by the groin wound as a major source
of new channels reconnecting superficial veins to the deep
femoral vein around a ligated SFJ. Thus, interference with
the venous drainage of the lower abdominal and pudendal
veins may promote new vessel formation. The absence of
neovascularization in the EVA without ligation group may be
explained by the closed technique that does not result in
groin haematoma and angiogenesis.
In conclusion, we found no difference in short-term
outcome between EVA and EVA with SFJ ligation. Estab-
lishing whether SFJ ligation results in a poorer long-term
outcome because of neovascularisation needs to be studied
in larger populations with longer follow-up.
Limitations
The participants and the observers in the study were
obviously aware of which intervention was performed due
to scarring in the groin (lack of blinding).
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